Global Imipenem and Cilastatin Sodium for Injection Market Research Report 2026

Imipenem and Cilastatin Sodium for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Imipenem and Cilastatin Sodium for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Imipenem and Cilastatin Sodium for Injection is a well-established carbapenem combination antibiotic formulated at a fixed ratio, in which cilastatin sodium acts as a dehydropeptidase inhibitor to protect imipenem from renal metabolism while maintaining strong antibacterial activity against Gram-negative, Gram-positive, and anaerobic pathogens. It is widely used in the treatment of severe pneumonia, sepsis, complicated intra-abdominal infections, complicated skin and soft tissue infections, and serious hospital-acquired infections associated with multidrug-resistant bacteria. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, cilastatin sodium raw material, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile glass vials and rubber stoppers, as well as high-standard GMP-compliant aseptic manufacturing and testing equipment, all of which require stringent control of synthesis processes, impurity profiles, and sterility assurance. Downstream customers primarily consist of general hospitals, tertiary hospitals, regional medical centers, and selected specialty hospitals, with utilization driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of imipenem and cilastatin sodium for injection in 2025 is estimated at approximately 56.0 million vials, with actual sales volume of around 43.65 million vials and an average global ex-factory price of about USD 10.4 per vial. Influenced by technical barriers in sterile manufacturing, intensive quality system requirements, and sustained pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 42%–58%, reflecting a mature product category with stable demand, competitive dynamics, and scale- and compliance-driven profitability.

From a market perspective, the hospital anti-infective segment for imipenem and cilastatin sodium injection has reached a highly mature and regulated stage. As one of the earlier carbapenem combination therapies introduced into clinical practice, it has established stable treatment pathways and broad clinical acceptance across hospital systems in many regions. Following patent expiry, the market has transitioned to a multi-generic structure, with competition shifting away from brand recognition toward comprehensive capabilities such as product quality consistency, regulatory coverage, and reliable long-term supply.

In terms of demand drivers, the ongoing burden of severe hospital-acquired infections, increased use of invasive medical procedures, and the need to manage multidrug-resistant pathogens continue to underpin clinical utilization. Although antimicrobial stewardship policies have become increasingly stringent, the clinical value of imipenem and cilastatin sodium remains well defined in specific severe and mixed-infection scenarios. Its use is increasingly characterized by targeted and protocol-driven deployment rather than broad or indiscriminate application.

Looking ahead, market development is expected to focus on structural optimization rather than volume expansion. Hospitals are placing greater emphasis on compliance, traceability, and supply continuity, which favors manufacturers with established aseptic production platforms and robust quality systems. At the same time, the introduction of newer antimicrobial agents, combination regimens, and differentiated carbapenem products may partially displace its use in certain indications, further narrowing its role to well-defined clinical settings and patient populations.

Against this backdrop, both drivers and constraints shape the long-term outlook. Cost-containment measures, centralized procurement, and antibiotic classification policies exert sustained pressure on pricing and utilization. Meanwhile, the technical and regulatory demands of sterile manufacturing increase sensitivity to upstream material availability and operational costs. For manufacturers, long-term competitiveness in this mature segment will depend on maintaining regulatory compliance, cost discipline, and dependable supply within an increasingly controlled healthcare environment.

This report delivers a comprehensive overview of the global Imipenem and Cilastatin Sodium for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Imipenem and Cilastatin Sodium for Injection. The Imipenem and Cilastatin Sodium for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Imipenem and Cilastatin Sodium for Injection market comprehensively. Regional market sizes by Type, by Application, by Clinical Indication, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Imipenem and Cilastatin Sodium for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Imipenem and Cilastatin Sodium for Injection Market Report

Chapter Outline

1.1 Product Definition

1.2 Imipenem and Cilastatin Sodium for Injection by Type

1.2.1 Global Imipenem and Cilastatin Sodium for Injection Market Value by Type: 2025 vs 2032

1.2.2 0.5g

1.2.3 1.0g

1.2.4 2.0g

1.3 Imipenem and Cilastatin Sodium for Injection by Clinical Indication

1.3.1 Global Imipenem and Cilastatin Sodium for Injection Market Value by Clinical Indication: 2025 vs 2032

1.3.2 Severe Hospital-acquired Infections

1.3.3 Multidrug-resistant Bacterial Infections

1.3.4 Others

1.4 Imipenem and Cilastatin Sodium for Injection by Sales Channels

1.4.1 Global Imipenem and Cilastatin Sodium for Injection Market Value by Sales Channels: 2025 vs 2032

1.4.2 Online Sales

1.4.3 Offline Sales

1.5 Imipenem and Cilastatin Sodium for Injection by Application

1.5.1 Global Imipenem and Cilastatin Sodium for Injection Market Value by Application: 2025 vs 2032

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Others

1.6 Global Imipenem and Cilastatin Sodium for Injection Market Size Estimates and Forecasts

1.6.1 Global Imipenem and Cilastatin Sodium for Injection Revenue 2021–2032

1.6.2 Global Imipenem and Cilastatin Sodium for Injection Sales 2021–2032

1.6.3 Global Imipenem and Cilastatin Sodium for Injection Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Manufacturers (2021–2026)

2.2 Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Imipenem and Cilastatin Sodium for Injection Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Imipenem and Cilastatin Sodium for Injection, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Imipenem and Cilastatin Sodium for Injection, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Imipenem and Cilastatin Sodium for Injection, Product Types and Applications

2.7 Global Key Manufacturers of Imipenem and Cilastatin Sodium for Injection, Date of Entry into the Industry

2.8 Global Imipenem and Cilastatin Sodium for Injection Market Competitive Situation and Trends

2.8.1 Global Imipenem and Cilastatin Sodium for Injection Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Imipenem and Cilastatin Sodium for Injection Players Market Share by Revenue

2.8.3 Global Imipenem and Cilastatin Sodium for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Imipenem and Cilastatin Sodium for Injection Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Imipenem and Cilastatin Sodium for Injection Sales by Region: 2021–2032

3.2.1 Global Imipenem and Cilastatin Sodium for Injection Sales by Region: 2021–2026

3.2.2 Global Imipenem and Cilastatin Sodium for Injection Sales by Region: 2027–2032

3.3 Global Imipenem and Cilastatin Sodium for Injection Revenue by Region: 2021–2032

3.3.1 Global Imipenem and Cilastatin Sodium for Injection Revenue by Region: 2021–2026

3.3.2 Global Imipenem and Cilastatin Sodium for Injection Revenue by Region: 2027–2032

3.4 North America Imipenem and Cilastatin Sodium for Injection Market Facts & Figures by Country

3.4.1 North America Imipenem and Cilastatin Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Imipenem and Cilastatin Sodium for Injection Sales by Country (2021–2032)

3.4.3 North America Imipenem and Cilastatin Sodium for Injection Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Imipenem and Cilastatin Sodium for Injection Market Facts & Figures by Country

3.5.1 Europe Imipenem and Cilastatin Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Imipenem and Cilastatin Sodium for Injection Sales by Country (2021–2032)

3.5.3 Europe Imipenem and Cilastatin Sodium for Injection Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Imipenem and Cilastatin Sodium for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Imipenem and Cilastatin Sodium for Injection Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Imipenem and Cilastatin Sodium for Injection Sales by Region (2021–2032)

3.6.3 Asia Pacific Imipenem and Cilastatin Sodium for Injection Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Imipenem and Cilastatin Sodium for Injection Market Facts & Figures by Country

3.7.1 Latin America Imipenem and Cilastatin Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Imipenem and Cilastatin Sodium for Injection Sales by Country (2021–2032)

3.7.3 Latin America Imipenem and Cilastatin Sodium for Injection Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Imipenem and Cilastatin Sodium for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Imipenem and Cilastatin Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Imipenem and Cilastatin Sodium for Injection Sales by Country (2021–2032)

3.8.3 Middle East and Africa Imipenem and Cilastatin Sodium for Injection Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Imipenem and Cilastatin Sodium for Injection Sales by Type (2021–2032)

4.1.1 Global Imipenem and Cilastatin Sodium for Injection Sales by Type (2021–2026)

4.1.2 Global Imipenem and Cilastatin Sodium for Injection Sales by Type (2027–2032)

4.1.3 Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Type (2021–2032)

4.2 Global Imipenem and Cilastatin Sodium for Injection Revenue by Type (2021–2032)

4.2.1 Global Imipenem and Cilastatin Sodium for Injection Revenue by Type (2021–2026)

4.2.2 Global Imipenem and Cilastatin Sodium for Injection Revenue by Type (2027–2032)

4.2.3 Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Type (2021–2032)

4.3 Global Imipenem and Cilastatin Sodium for Injection Price by Type (2021–2032)

5.1 Global Imipenem and Cilastatin Sodium for Injection Sales by Application (2021–2032)

5.1.1 Global Imipenem and Cilastatin Sodium for Injection Sales by Application (2021–2026)

5.1.2 Global Imipenem and Cilastatin Sodium for Injection Sales by Application (2027–2032)

5.1.3 Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Application (2021–2032)

5.2 Global Imipenem and Cilastatin Sodium for Injection Revenue by Application (2021–2032)

5.2.1 Global Imipenem and Cilastatin Sodium for Injection Revenue by Application (2021–2026)

5.2.2 Global Imipenem and Cilastatin Sodium for Injection Revenue by Application (2027–2032)

5.2.3 Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Application (2021–2032)

5.3 Global Imipenem and Cilastatin Sodium for Injection Price by Application (2021–2032)

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Merck Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Fresenius

6.2.1 Fresenius Company Information

6.2.2 Fresenius Description and Business Overview

6.2.3 Fresenius Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Fresenius Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.2.5 Fresenius Recent Developments/Updates

6.3 Venus Remedies

6.3.1 Venus Remedies Company Information

6.3.2 Venus Remedies Description and Business Overview

6.3.3 Venus Remedies Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Venus Remedies Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.3.5 Venus Remedies Recent Developments/Updates

6.4 Sun Pharmaceutical

6.4.1 Sun Pharmaceutical Company Information

6.4.2 Sun Pharmaceutical Description and Business Overview

6.4.3 Sun Pharmaceutical Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Sun Pharmaceutical Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.4.5 Sun Pharmaceutical Recent Developments/Updates

6.5 JW Pharmaceutical

6.5.1 JW Pharmaceutical Company Information

6.5.2 JW Pharmaceutical Description and Business Overview

6.5.3 JW Pharmaceutical Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 JW Pharmaceutical Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.5.5 JW Pharmaceutical Recent Developments/Updates

6.6 Taiwan Biotech

6.6.1 Taiwan Biotech Company Information

6.6.2 Taiwan Biotech Description and Business Overview

6.6.3 Taiwan Biotech Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Taiwan Biotech Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.6.5 Taiwan Biotech Recent Developments/Updates

6.7 Zhuhai United Laboratories

6.7.1 Zhuhai United Laboratories Company Information

6.7.2 Zhuhai United Laboratories Description and Business Overview

6.7.3 Zhuhai United Laboratories Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Zhuhai United Laboratories Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.7.5 Zhuhai United Laboratories Recent Developments/Updates

6.8 Hanhui Pharmaceuticals

6.8.1 Hanhui Pharmaceuticals Company Information

6.8.2 Hanhui Pharmaceuticals Description and Business Overview

6.8.3 Hanhui Pharmaceuticals Imipenem and Cilastatin Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Hanhui Pharmaceuticals Imipenem and Cilastatin Sodium for Injection Product Portfolio

6.8.5 Hanhui Pharmaceuticals Recent Developments/Updates

7.1 Imipenem and Cilastatin Sodium for Injection Industry Chain Analysis

7.2 Imipenem and Cilastatin Sodium for Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Imipenem and Cilastatin Sodium for Injection Production Mode & Process Analysis

7.4 Imipenem and Cilastatin Sodium for Injection Sales and Marketing

7.4.1 Imipenem and Cilastatin Sodium for Injection Sales Channels

7.4.2 Imipenem and Cilastatin Sodium for Injection Distributors

7.5 Imipenem and Cilastatin Sodium for Injection Customer Analysis

8.1 Imipenem and Cilastatin Sodium for Injection Industry Trends

8.2 Imipenem and Cilastatin Sodium for Injection Market Drivers

8.3 Imipenem and Cilastatin Sodium for Injection Market Challenges

8.4 Imipenem and Cilastatin Sodium for Injection Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Imipenem and Cilastatin Sodium for Injection Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Imipenem and Cilastatin Sodium for Injection Market Value by Clinical Indication (US$ Million), 2025 vs 2032

 Table 3. Global Imipenem and Cilastatin Sodium for Injection Market Value by Sales Channels (US$ Million), 2025 vs 2032

 Table 4. Global Imipenem and Cilastatin Sodium for Injection Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Imipenem and Cilastatin Sodium for Injection Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Imipenem and Cilastatin Sodium for Injection Sales (K Units) of Key Manufacturers (2021–2026)

 Table 7. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Imipenem and Cilastatin Sodium for Injection Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Imipenem and Cilastatin Sodium for Injection Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Imipenem and Cilastatin Sodium for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Imipenem and Cilastatin Sodium for Injection, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Imipenem and Cilastatin Sodium for Injection, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Imipenem and Cilastatin Sodium for Injection, Product Types and Applications

 Table 14. Global Key Manufacturers of Imipenem and Cilastatin Sodium for Injection, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Imipenem and Cilastatin Sodium for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Imipenem and Cilastatin Sodium for Injection Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Imipenem and Cilastatin Sodium for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Imipenem and Cilastatin Sodium for Injection Sales by Region (K Units), 2021–2026

 Table 20. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Region (2021–2026)

 Table 21. Global Imipenem and Cilastatin Sodium for Injection Sales by Region (K Units), 2027–2032

 Table 22. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Region (2027–2032)

 Table 23. Global Imipenem and Cilastatin Sodium for Injection Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Region (2021–2026)

 Table 25. Global Imipenem and Cilastatin Sodium for Injection Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Region (2027–2032)

 Table 27. North America Imipenem and Cilastatin Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2021–2026

 Table 29. North America Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2027–2032

 Table 30. North America Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Imipenem and Cilastatin Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2021–2026

 Table 34. Europe Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2027–2032

 Table 35. Europe Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Imipenem and Cilastatin Sodium for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Imipenem and Cilastatin Sodium for Injection Sales by Region (K Units), 2021–2026

 Table 39. Asia Pacific Imipenem and Cilastatin Sodium for Injection Sales by Region (K Units), 2027–2032

 Table 40. Asia Pacific Imipenem and Cilastatin Sodium for Injection Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Imipenem and Cilastatin Sodium for Injection Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Imipenem and Cilastatin Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2021–2026

 Table 44. Latin America Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2027–2032

 Table 45. Latin America Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2021–2026

 Table 49. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Sales by Country (K Units), 2027–2032

 Table 50. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Imipenem and Cilastatin Sodium for Injection Sales (K Units) by Type (2021–2026)

 Table 53. Global Imipenem and Cilastatin Sodium for Injection Sales (K Units) by Type (2027–2032)

 Table 54. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Type (2021–2026)

 Table 55. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Type (2027–2032)

 Table 56. Global Imipenem and Cilastatin Sodium for Injection Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Imipenem and Cilastatin Sodium for Injection Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Type (2021–2026)

 Table 59. Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Type (2027–2032)

 Table 60. Global Imipenem and Cilastatin Sodium for Injection Price (US$/Unit) by Type (2021–2026)

 Table 61. Global Imipenem and Cilastatin Sodium for Injection Price (US$/Unit) by Type (2027–2032)

 Table 62. Global Imipenem and Cilastatin Sodium for Injection Sales (K Units) by Application (2021–2026)

 Table 63. Global Imipenem and Cilastatin Sodium for Injection Sales (K Units) by Application (2027–2032)

 Table 64. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Application (2021–2026)

 Table 65. Global Imipenem and Cilastatin Sodium for Injection Sales Market Share by Application (2027–2032)

 Table 66. Global Imipenem and Cilastatin Sodium for Injection Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Imipenem and Cilastatin Sodium for Injection Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Application (2021–2026)

 Table 69. Global Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Application (2027–2032)

 Table 70. Global Imipenem and Cilastatin Sodium for Injection Price (US$/Unit) by Application (2021–2026)

 Table 71. Global Imipenem and Cilastatin Sodium for Injection Price (US$/Unit) by Application (2027–2032)

 Table 72. Merck Company Information

 Table 73. Merck Description and Business Overview

 Table 74. Merck Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 75. Merck Imipenem and Cilastatin Sodium for Injection Product

 Table 76. Merck Recent Developments/Updates

 Table 77. Fresenius Company Information

 Table 78. Fresenius Description and Business Overview

 Table 79. Fresenius Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 80. Fresenius Imipenem and Cilastatin Sodium for Injection Product

 Table 81. Fresenius Recent Developments/Updates

 Table 82. Venus Remedies Company Information

 Table 83. Venus Remedies Description and Business Overview

 Table 84. Venus Remedies Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 85. Venus Remedies Imipenem and Cilastatin Sodium for Injection Product

 Table 86. Venus Remedies Recent Developments/Updates

 Table 87. Sun Pharmaceutical Company Information

 Table 88. Sun Pharmaceutical Description and Business Overview

 Table 89. Sun Pharmaceutical Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 90. Sun Pharmaceutical Imipenem and Cilastatin Sodium for Injection Product

 Table 91. Sun Pharmaceutical Recent Developments/Updates

 Table 92. JW Pharmaceutical Company Information

 Table 93. JW Pharmaceutical Description and Business Overview

 Table 94. JW Pharmaceutical Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 95. JW Pharmaceutical Imipenem and Cilastatin Sodium for Injection Product

 Table 96. JW Pharmaceutical Recent Developments/Updates

 Table 97. Taiwan Biotech Company Information

 Table 98. Taiwan Biotech Description and Business Overview

 Table 99. Taiwan Biotech Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 100. Taiwan Biotech Imipenem and Cilastatin Sodium for Injection Product

 Table 101. Taiwan Biotech Recent Developments/Updates

 Table 102. Zhuhai United Laboratories Company Information

 Table 103. Zhuhai United Laboratories Description and Business Overview

 Table 104. Zhuhai United Laboratories Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 105. Zhuhai United Laboratories Imipenem and Cilastatin Sodium for Injection Product

 Table 106. Zhuhai United Laboratories Recent Developments/Updates

 Table 107. Hanhui Pharmaceuticals Company Information

 Table 108. Hanhui Pharmaceuticals Description and Business Overview

 Table 109. Hanhui Pharmaceuticals Imipenem and Cilastatin Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 110. Hanhui Pharmaceuticals Imipenem and Cilastatin Sodium for Injection Product

 Table 111. Hanhui Pharmaceuticals Recent Developments/Updates

 Table 112. Key Raw Materials Lists

 Table 113. Raw Materials Key Suppliers Lists

 Table 114. Imipenem and Cilastatin Sodium for Injection Distributors List

 Table 115. Imipenem and Cilastatin Sodium for Injection Customers List

 Table 116. Imipenem and Cilastatin Sodium for Injection Market Trends

 Table 117. Imipenem and Cilastatin Sodium for Injection Market Drivers

 Table 118. Imipenem and Cilastatin Sodium for Injection Market Challenges

 Table 119. Imipenem and Cilastatin Sodium for Injection Market Restraints

 Table 120. Research Programs/Design for This Report

 Table 121. Key Data Information from Secondary Sources

 Table 122. Key Data Information from Primary Sources

 Table 123. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Imipenem and Cilastatin Sodium for Injection

 Figure 2. Global Imipenem and Cilastatin Sodium for Injection Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Imipenem and Cilastatin Sodium for Injection Market Share by Type: 2025 & 2032

 Figure 4. 0.5g Product Picture

 Figure 5. 1.0g Product Picture

 Figure 6. 2.0g Product Picture

 Figure 7. Global Imipenem and Cilastatin Sodium for Injection Market Value by Clinical Indication (US$ Million), 2021–2032

 Figure 8. Global Imipenem and Cilastatin Sodium for Injection Market Share by Clinical Indication: 2025 vs 2032

 Figure 9. Severe Hospital-acquired Infections Product Picture

 Figure 10. Multidrug-resistant Bacterial Infections Product Picture

 Figure 11. Others Product Picture

 Figure 12. Global Imipenem and Cilastatin Sodium for Injection Market Value by Sales Channels (US$ Million), 2021–2032

 Figure 13. Global Imipenem and Cilastatin Sodium for Injection Market Share by Sales Channels: 2025 vs 2032

 Figure 14. Online Sales Product Picture

 Figure 15. Offline Sales Product Picture

 Figure 16. Global Imipenem and Cilastatin Sodium for Injection Market Value by Application (US$ Million), 2021–2032

 Figure 17. Global Imipenem and Cilastatin Sodium for Injection Market Share by Application: 2025 & 2032

 Figure 18. Hospital

 Figure 19. Clinic

 Figure 20. Others

 Figure 21. Global Imipenem and Cilastatin Sodium for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 22. Global Imipenem and Cilastatin Sodium for Injection Market Size (US$ Million), 2021–2032

 Figure 23. Global Imipenem and Cilastatin Sodium for Injection Sales (K Units), 2021–2032

 Figure 24. Global Imipenem and Cilastatin Sodium for Injection Average Price (US$/Unit), 2021–2032

 Figure 25. Imipenem and Cilastatin Sodium for Injection Report Years Considered

 Figure 26. Imipenem and Cilastatin Sodium for Injection Sales Share by Manufacturers in 2025

 Figure 27. Global Imipenem and Cilastatin Sodium for Injection Revenue Share by Manufacturers in 2025

 Figure 28. Top 5 and Top 10 Global Imipenem and Cilastatin Sodium for Injection Players: Market Share by Revenue in Imipenem and Cilastatin Sodium for Injection in 2025

 Figure 29. Imipenem and Cilastatin Sodium for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 30. Global Imipenem and Cilastatin Sodium for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 31. North America Imipenem and Cilastatin Sodium for Injection Sales Market Share by Country (2021–2032)

 Figure 32. North America Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Country (2021–2032)

 Figure 33. United States Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 34. Canada Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 35. Europe Imipenem and Cilastatin Sodium for Injection Sales Market Share by Country (2021–2032)

 Figure 36. Europe Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Country (2021–2032)

 Figure 37. Germany Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. France Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. U.K. Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Italy Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Russia Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 42. Asia Pacific Imipenem and Cilastatin Sodium for Injection Sales Market Share by Region (2021–2032)

 Figure 43. Asia Pacific Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Region (2021–2032)

 Figure 44. China Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. Japan Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. South Korea Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. India Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. Australia Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. China Taiwan Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. Southeast Asia Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Latin America Imipenem and Cilastatin Sodium for Injection Sales Market Share by Country (2021–2032)

 Figure 52. Latin America Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Country (2021–2032)

 Figure 53. Mexico Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 54. Brazil Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. Argentina Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Sales Market Share by Country (2021–2032)

 Figure 57. Middle East and Africa Imipenem and Cilastatin Sodium for Injection Revenue Market Share by Country (2021–2032)

 Figure 58. Turkey Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 59. Saudi Arabia Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. UAE Imipenem and Cilastatin Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. Global Sales Market Share of Imipenem and Cilastatin Sodium for Injection by Type (2021–2032)

 Figure 62. Global Revenue Market Share of Imipenem and Cilastatin Sodium for Injection by Type (2021–2032)

 Figure 63. Global Imipenem and Cilastatin Sodium for Injection Price (US$/Unit) by Type (2021–2032)

 Figure 64. Global Sales Market Share of Imipenem and Cilastatin Sodium for Injection by Application (2021–2032)

 Figure 65. Global Revenue Market Share of Imipenem and Cilastatin Sodium for Injection by Application (2021–2032)

 Figure 66. Global Imipenem and Cilastatin Sodium for Injection Price (US$/Unit) by Application (2021–2032)

 Figure 67. Imipenem and Cilastatin Sodium for Injection Value Chain

 Figure 68. Channels of Distribution (Direct Vs Distribution)

 Figure 69. Bottom-up and Top-down Approaches for This Report

 Figure 70. Data Triangulation

 Figure 71. Key Executives Interviewed